Felix Unverdorben

This inventor holds 14 USPTO granted patents and 21 published patent applications and 5 EPO patents. Top assignees: Immatics Biotechnologies Gmbh, Emmatics Biotechmiogieg Gmbh, Universitãt Stuttgart. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Felix Unverdorben. Retrieved from https://idiyas.com/inventor/felix-unverdorben

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 21)

% Patents Active = 92.9

EPO Patents = 5 (Patent Applications = 17)

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 27(Granted Patents)

Location History:

Stuttgart, DE (2019 - 2024)
Tuebingen, DE (2024)

Company Filing History:

12 out of 728

Immatics Biotechnologies Gmbh

patents

1 out of 1

Emmatics Biotechmiogieg Gmbh

patent

1 out of 114

Universitãt Stuttgart

patents

Years Active: 2019-2026

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570760 - Antigen binding proteins specifically binding PRAME (2026-03-10),

2. 12480958 - METHOD FOR THE CHARACTERIZATION OF PEPTIDE:MHC BINDING POLYPEPTIDES (2025-11-25),

3. 12269881 - Antigen binding proteins specifically binding MAGE-A (2025-04-08),

4. 12209137 - Antigen binding proteins specifically binding CT45 (2025-01-28),

5. 12162940 - BMA031 antigen binding polypeptides (2024-12-10),

6. 11932689 - Engineered T cell receptors and immune therapy using the same (2024-03-19),

7. 11905328 - Dual specificity polypeptide molecule (2024-02-20),

8. 11859009 - Antigen binding proteins specifically binding PRAME (2024-01-02),

9. 11840577 - Antigen binding proteins specifically binding MAGE-A (2023-12-12),

10. 11104894 - Method for preparing electrocompetent yeast cells, and method for using said cells (2021-08-31),

11. 10889645 - Engineered T cell receptors and immune therapy using the same (2021-01-12),

12. 10683495 - Method for preparing electrocompetent yeast cells, and method for using said cells (2020-06-16),

13. 10618956 - Engineered T cell receptors and immune therapy using the same (2020-04-14),

14. 10428120 - Serum half-life extension using IgBD (2019-10-01),

Title: Felix Unverdorben - Innovative Inventor from Stuttgart

Introduction: Felix Unverdorben is a renowned inventor hailing from Stuttgart, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Felix Unverdorben holds several patents in the areas of renewable energy, automotive engineering, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: Throughout his career, Felix Unverdorben has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized industries. His passion for innovation and problem-solving has led to the creation of numerous successful inventions.

Collaborations: Felix Unverdorben has collaborated with top engineers, scientists, and designers from around the world, bringing together diverse perspectives to drive innovation forward. His collaborative spirit and dedication to excellence have been instrumental in his success as an inventor.

Conclusion: Felix Unverdorben's relentless pursuit of innovation and his commitment to pushing the boundaries of technology have established him as a visionary inventor in the global innovation landscape.

Profile summary based on public USPTO records.